Skip to main content

Technological offer

Available technologies catalogue

Available Technological Offer

Technological category
Two different vaccines prototypes have been developed based on RNA replicons from SARS-CoV-2 and MERS-CoV, encapsulated in Virus-Like Particles (VLPs), which can be used as a vaccines to generate immunity and protect against infections by these coronavirus.
New family of molecules with potent and selective antiviral activity in cellular models of infection by various coronaviruses such as SARS-CoV-2, MERS-CoV, hCoV-229E. They do not show cytotoxicity or activity against other viruses with RNA genome such as West Nile fever virus, dengue virus and vesicular stomatitis virus at relevant doses.
The modulation of specific endogenous hormonal flows in neural routes has been observed to allow the modulation of social interaction preferences, opening the door to new therapies against social avoidance disorders
Immunochemical method for diagnosis of infections produced by Pseudomonas aeruginosa targeting the main signalling molecules of the pqs Quorum Sensing system. The immunoassay is fast and efficient, with low LOD and adaptable to point-of-care devices.
Early and accurate diagnosis and follow up of diseases related to cystine accumulation, such as cystinosis and cystinuria, based on a molecular network producing a signal measurable by fluorescence when certain substances bind to cysteine or cystine, allowing abnormal levels of cystine to be detected.

Social Media